Notice2021-19222
Solicitation of Nominations for Membership on the Lead Exposure and Prevention Advisory Committee (LEPAC)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 7, 2021
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC) is soliciting nominations for membership on the LEPAC. The LEPAC is composed of 15 members that are Federal and non-Federal experts in fields associated with lead screening, the prevention of lead exposure, and services for individuals and communities affected by lead exposure. Nominations are being sought for individuals with expertise in the fields of epidemiology, toxicology, mental health, pediatrics, early childhood education, special education, diet and nutrition, and environmental health. Members may be invited to serve for three-year terms. Selection of members is based on candidates' qualifications to contribute to the accomplishment of LEPAC objectives.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 170 (Tuesday, September 7, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 170 (Tuesday, September 7, 2021)]
[Notices]
[Pages 50129-50130]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-19222]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Membership on the Lead Exposure
and Prevention Advisory Committee (LEPAC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) is
soliciting nominations for membership on the LEPAC. The LEPAC is
composed of 15 members that are Federal and non-Federal experts in
fields associated with lead screening, the prevention of lead exposure,
and services for individuals and communities affected by lead exposure.
Nominations are being sought for individuals with expertise in the
fields of epidemiology, toxicology, mental health, pediatrics, early
childhood education, special education, diet and nutrition, and
environmental health. Members may be invited to serve for three-year
terms. Selection of members is based on candidates' qualifications to
contribute to the accomplishment of LEPAC objectives.
DATES: Nominations for membership on the LEPAC must be received no
later than November 1, 2021. Packages received after this time will not
be considered for the current membership cycle.
ADDRESSES: All nominations should be emailed to <a href="/cdn-cgi/l/email-protection#9fd3dacfdedcdffcfbfcb1f8f0e9"><span class="__cf_email__" data-cfemail="4f030a1f0e0c0f2c2b2c61282039">[email protected]</span></a>.
FOR FURTHER INFORMATION CONTACT: Paul Allwood, Ph.D., M.P.H.,
Designated Federal Officer, National Center for Environmental Health,
CDC, 4770 Buford Highway NE, Atlanta, GA 30329-4018, Telephone: (770)
488-6774, <a href="/cdn-cgi/l/email-protection#d68697babaa1b9b9b296b5b2b5f8b1b9a0"><span class="__cf_email__" data-cfemail="18485974746f77777c587b7c7b367f776e">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The members of this committee are selected
by the Secretary of the U.S. Department of Health and Human Services
(HHS). The committee's objective is to advise the Secretary, HHS and
the Director, Centers for Disease Control and Prevention/Administrator,
Agency for Toxic Substances and Disease Registry on a range of
activities to include: (1) Review of Federal programs and services
available to individuals and communities exposed to lead; (2) review of
the current research on lead exposure to identify additional research
needs;(3) review of and identification of best practices, or the need
for best practices regarding lead screening and the prevention of lead
exposure; (4) identification of effective services, including services
relating to healthcare, education, and nutrition for individuals and
communities affected by lead exposure and lead poisoning, including in
consultation with, as appropriate, the lead exposure registry as
established in Public Law 114-322 Section 2203(b) (42 U.S.C. 300j-27);
and (5) undertaking of any other review or activities that the
Secretary determines to be appropriate.
Annually as determined necessary by the Secretary or as required by
Congress, the committee shall submit a report to include: (1) An
evaluation of the effectiveness of the Federal programs and services
available to individuals and communities exposed to lead; (2) an
evaluation of additional lead exposure research needs; (3) an
assessment of any effective screening methods or best practices used or
developed to prevent or screen for lead exposure; (4) input and
recommendations for improved access to effective services relating to
health care, education, or nutrition for individuals and communities
impacted by lead exposure; and (5) any other recommendations for
communities
[[Page 50130]]
affected by lead exposure, as appropriate.
At least half of the committee will consist of Federal
representatives from a range of agencies that may include the
Department of Housing and Urban Development; the Environmental
Protection Agency; the Consumer Product Safety Commission; the Centers
for Medicare and Medicaid Services; the Health Resources and Services
Administration; the Food and Drug Administration; the U.S. Department
of Agriculture; the Occupational Safety and Health Administration; the
National Institute of Environmental Health Sciences; the U.S.
Geological Survey; and such additional federal, state, tribal, and
local public and private officials as the Secretary deems necessary for
the committee to carry out its function. The rest of the committee will
consist of non-Federal members. Only non-Federal members are being
solicited with this announcement.
The U.S. Department of Health and Human Services policy stipulates
that committee membership be balanced in terms of points of view
represented, and the committee's function. Appointments shall be made
without discrimination on the basis of age, race, ethnicity, gender,
sexual orientation, gender identity, HIV status, disability, and
cultural, religious, or socioeconomic status. Nominees must be U.S.
citizens and cannot be full-time employees of the U.S. Government.
Current participation on federal workgroups or prior experience serving
on a federal advisory committee does not disqualify a candidate;
however, HHS policy is to avoid excessive individual service on
advisory committees and multiple committee memberships.
Committee members are Special Government Employees, requiring the
filing of financial disclosure reports at the beginning and annually
during their terms. CDC reviews potential candidates for LEPAC
membership each year and provides a slate of nominees for consideration
to the Secretary of HHS for final selection. HHS notifies selected
candidates of their appointment as soon as the HHS selection process is
completed. Note that the need for different expertise varies from year
to year and a candidate who is not selected in one year may be
reconsidered in a subsequent year. Candidates should submit the
following items:
<bullet> Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, email address).
<bullet> At least one letter of recommendation from person(s) not
employed by the U.S. Department of Health and Human Services.
(Candidates may submit letter(s) from current HHS employees if they
wish, but at least one letter must be submitted by a person not
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.)
Nominations may be submitted by the candidate him- or herself or by
the person/organization recommending the candidate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-19222 Filed 9-3-21; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 7, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.